Wells Fargo & Company Sangamo Therapeutics, Inc Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Wells Fargo & Company holds 64,973 shares of SGMO stock, worth $132,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,973

Previous 134,357 51.64%

Holding current value

$132,544

Previous $90,000 74.44%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.36 - $0.65 $24,978 - $45,099	-69,384 Reduced 51.64%	64,973 $23,000
Q1 2024 May 10, 2024	SELL	$0.42 - $1.38 $15,350 - $50,436	-36,548 Reduced 21.38%	134,357 $90,000
Q4 2023 Feb 09, 2024	SELL	$0.3 - $0.63 $46,129 - $96,872	-153,766 Reduced 47.36%	170,905 $92,000
Q3 2023 Nov 13, 2023	SELL	$0.58 - $1.47 $12,993 - $32,930	-22,402 Reduced 6.45%	324,671 $194,000
Q2 2023 Aug 15, 2023	SELL	$1.11 - $1.74 $185,708 - $291,110	-167,305 Reduced 32.53%	347,073 $451,000
Q1 2023 May 12, 2023	BUY	$1.66 - $3.67 $189,082 - $418,031	113,905 Added 28.44%	514,378 $905,000
Q4 2022 Feb 13, 2023	SELL	$2.77 - $5.07 $126,107 - $230,816	-45,526 Reduced 10.21%	400,473 $1.26 Million
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $125,888 - $188,389	-29,482 Reduced 6.2%	445,999 $2.19 Million
Q2 2022 Aug 12, 2022	SELL	$3.28 - $6.21 $356,211 - $674,412	-108,601 Reduced 18.59%	475,481 $1.97 Million
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $107,853 - $161,264	-20,622 Reduced 3.41%	584,082 $3.39 Million
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $379,881 - $571,646	-52,110 Reduced 7.93%	604,704 $4.54 Million
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $300,780 - $400,929	-33,383 Reduced 4.84%	656,814 $5.92 Million
Q2 2021 Aug 16, 2021	BUY	$10.17 - $12.64 $317,731 - $394,898	31,242 Added 4.74%	690,197 $8.26 Million
Q1 2021 May 13, 2021	SELL	$10.88 - $17.05 $1.44 Million - $2.25 Million	-132,125 Reduced 16.7%	658,955 $8.26 Million
Q4 2020 Feb 09, 2021	SELL	$9.23 - $18.18 $534,786 - $1.05 Million	-57,940 Reduced 6.82%	791,080 $12.3 Million
Q3 2020 Nov 05, 2020	BUY	$9.38 - $12.48 $324,820 - $432,169	34,629 Added 4.25%	849,020 $8.02 Million
Q2 2020 Aug 13, 2020	BUY	$6.21 - $11.83 $902,027 - $1.72 Million	145,254 Added 21.71%	814,391 $7.3 Million
Q1 2020 May 14, 2020	BUY	$5.05 - $8.85 $3.38 Million - $5.92 Million	669,137 New	669,137 $4.26 Million

Others Institutions Holding SGMO

# of Institutions

135

Shares Held

86.5M

Call Options Held

35.9K

Put Options Held

156K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $319M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Sangamo Therapeutics, Inc Transaction History